SynBioBeta Speaker
Melanie Silvis
Senior Scientist
Epicrispr Biotechnologies
Melanie has been a researcher in CRISPR technology development for the past 12 years, spanning work in both academia and industry, with a current focus on optimizing CRISPR-based tools for the next generation of gene therapies. In her current role at Epicrispr Biotechnologies, she leads teams characterizing the targeting potential and precision of dCas proteins (the targeting component of Epicrispr GEMS technology), and applying GEMS in disease relevant models to mitigate and reverse the effects of gene dysregulation in disease. In her work, she is motivated by the challenges of deploying engineered, compact, and precise gene regulators to affected tissues to improve patient health."
SynBioBeta 2025 - Session Speaker
The Living Future: How SynBio, Genomics, and Regenerative Medicine are Transforming Human Health
Synthetic biology is blurring the lines between biology and technology, unlocking breakthroughs in regenerative medicine, biofabrication, and personalized healthcare. This panel brings together leading innovators who are shaping the future of human health. Join this session to explore the role of multidisciplinary technologies in healthcare. Understand how genomics, synthetic biology, and regenerative medicine are personalizing treatment and examine the ethical and practical challenges in deploying next-gen biotechnologies.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
23:02:57:01
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates